HOSPIDANA ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  1.5% 1.8% 0.9% 0.9% 0.8%  
Credit score (0-100)  77 71 88 89 90  
Credit rating  A A A A AA  
Credit limit (kDKK)  22.4 2.7 530.2 571.1 766.9  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  6,776 6,614 7,438 7,544 8,737  
EBITDA  1,247 1,198 2,161 2,003 2,415  
EBIT  -337 -370 641 658 1,090  
Pre-tax profit (PTP)  -434.8 -448.3 570.8 548.4 621.1  
Net earnings  -340.6 -349.3 444.7 446.5 481.7  
Pre-tax profit without non-rec. items  -435 -448 571 548 621  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  15,199 13,685 12,748 12,008 12,155  
Shareholders equity total  5,828 5,478 5,923 6,370 6,851  
Interest-bearing liabilities  13,025 10,163 11,223 13,740 11,621  
Balance sheet total (assets)  22,860 20,545 21,622 23,119 22,322  

Net Debt  12,766 10,163 11,223 13,740 11,621  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  6,776 6,614 7,438 7,544 8,737  
Gross profit growth  -11.3% -2.4% 12.5% 1.4% 15.8%  
Employees  16 0 12 12 13  
Employee growth %  0.0% -100.0% 0.0% 0.0% 8.3%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  22,860 20,545 21,622 23,119 22,322  
Balance sheet change%  7.3% -10.1% 5.2% 6.9% -3.4%  
Added value  1,247.1 1,197.9 2,161.5 2,178.2 2,415.1  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  562 -3,082 -2,457 -2,085 -1,177  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 -2.0 1.0 2.0 3.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -5.0% -5.6% 8.6% 8.7% 12.5%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -1.3% -1.4% 3.3% 3.4% 5.3%  
ROI %  -1.4% -1.6% 3.8% 3.7% 5.7%  
ROE %  -5.5% -6.2% 7.8% 7.3% 7.3%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  25.5% 26.7% 27.4% 27.6% 30.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  1,023.7% 848.5% 519.2% 685.9% 481.2%  
Gearing %  223.5% 185.5% 189.5% 215.7% 169.6%  
Net interest  0 0 0 0 0  
Financing costs %  1.3% 1.2% 1.1% 1.7% 4.6%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.2 0.1 0.1 0.3 0.3  
Current Ratio  0.5 0.5 0.6 0.7 0.7  
Cash and cash equivalent  258.4 0.0 0.0 0.0 0.0  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -7,415.0 -6,361.6 -5,047.8 -3,988.4 -3,715.4  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  78 0 180 182 186  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  78 0 180 167 186  
EBIT / employee  -21 0 53 55 84  
Net earnings / employee  -21 0 37 37 37